Clinical Trials
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9632
Enhancing Well-Being During Breast Cancer Recurrence
Activated
06-01-1997
Closed
08-01-1998
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9629
A Phase II Trial of 5-Fluorouracil Plus 776C85 in Patients with Advanced Pancreas Cancer
Activated
05-15-1997
Closed
03-15-1999
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9714
A Phase II Trial of Paclitaxel by 96-Hour Infusion in Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC)
Research Committee(s)
Lung Cancer
Activated
05-15-1997
Closed
03-15-2000
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9625
Weekly Dose-Intensive Doxorubicin with Daily Oral Cyclophosphamide and Continuous G-CSF as Neoadjuvant Therapy for Locally Advanced and Inflammatory Breast Cancer, Phase II
Research Committee(s)
Breast Cancer
Activated
04-15-1997
Closed
08-15-1998
Closed
Phase
Accrual
95%
Published
SWOG Clinical Trial Number
S9630
A Randomized Comparison of Medroxyprogesterone Acetate (MPA) and Observation For Prevention of Endometrial Pathology in Postmenopausal Breast Cancer Patients Treated with Tamoxifen
Research Committee(s)
Breast Cancer
Activated
03-15-1997
Closed
12-15-2004
Closed
Phase
Accrual
32%
Published
SWOG Clinical Trial Number
SWOG-9427
Evaluation of Suramin in Advanced Adrenal Cortical Carcinoma, Phase II
Research Committee(s)
Genitourinary Cancer
Activated
03-01-1997
Closed
06-01-2000
Closed
Phase
Accrual
58%
Published
SWOG Clinical Trial Number
S9627
Hydroxyurea, Etoposide (VP-16) and Dacarbazine (DTIC) [HED] for Patients with Unresectable or Metastatic GI Stromal Tumors, Phase II
Research Committee(s)
Sarcoma
Activated
03-01-1997
Closed
03-01-1999
Closed
Phase
Accrual
43%
Published
SWOG Clinical Trial Number
SWOG-9342
A Study of the Late Cardiac Effects of Two Different Adjuvant Chemotherapy Regimens in Women With Node Negative Breast Cancer Treated on SWOG-8897
Research Committee(s)
Breast Cancer
Activated
02-15-1997
Closed
11-15-2003
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9511
A Phase II Study of Trimetrexate, 5-FU and Leucovorin in Unresectable or Metastatic Adenocarcinoma of the Stomach
Activated
01-15-1997
Closed
11-15-1998
Closed
Phase
Accrual
55%
Published
SWOG Clinical Trial Number
S9622
Evaluation of CI-980 in Patients with Disseminated Malignant Melanoma and No Prior Chemotherapy, Phase II
Research Committee(s)
Melanoma
Activated
12-15-1996
Closed
08-01-1998
Closed
Phase
Accrual
70%
Published
SWOG Clinical Trial Number
SWOG-9430
A Phase II Trial of Complete Surgical Resection for Stage IV Melanoma-Surgical Resection with Biological and Clinical Follow-Up
Research Committee(s)
Melanoma
Activated
11-15-1996
Closed
11-15-2005
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-9431
Cytogenetic, Molecular and Cellular Biology Studies in Metastatic Melanoma Patients, Ancillary
Research Committee(s)
Melanoma
Activated
11-15-1996
Closed
12-15-2005
Closed
Phase
Accrual
93%
Published
SWOG Clinical Trial Number
S9628
Phase II Study of Dexamethasone/Alpha Interferon In AL Amyloidosis
Research Committee(s)
Myeloma
Activated
11-01-1996
Closed
03-15-2003
Closed
Phase
Accrual
78%
Published
SWOG Clinical Trial Number
SWOG-9510
Evaluation of Topotecan in Hormone Refractory Prostate Cancer, Phase II
Research Committee(s)
Genitourinary Cancer
Activated
11-01-1996
Closed
08-15-1999
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9617
A Phase I Study of PSC833 As Chemotherapy – Resistance Modifier in Patients Over Age 55 With Previously Untreated Myeloid Leukemia (AML).
Research Committee(s)
Leukemia
Activated
11-01-1996
Closed
09-01-1998
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9504
A Phase II Trial of Concurrent Cisplatin/VP-16 and Radiotherapy Followed by Consolidation Docetaxel (Taxotere®) in Stage III-B Non-Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
10-15-1996
Closed
12-01-1998
Closed
Phase
Accrual
96%
Published
SWOG Clinical Trial Number
S9618
Closed
Phase
Accrual
86%
Published
SWOG Clinical Trial Number
SWOG-9457
Paclitaxel (Taxol®) and Carboplatin for Advanced Transitional Cell Carcinoma of the Urothelium, Phase II
Research Committee(s)
Genitourinary Cancer
Activated
07-15-1996
Closed
04-15-2000
Closed
Phase
Accrual
55%
Published
SWOG Clinical Trial Number
S9623
A Comparison of Intensive Sequential Chemotherapy using Doxorubicin plus Paclitaxel plus Cyclophosphamide with High Dose Chemotherapy and Autologous Hematopoietic Progenitor Cell Support for Primary Breast Cancer in Women with >= 4 Involved Axillary Lymph Nodes, Phase III, Intergroup.
Research Committee(s)
Breast Cancer
Activated
07-01-1996
Closed
02-15-2001
Closed
Phase
Accrual
68%
Published
SWOG Clinical Trial Number
SWOG-9519
Evaluation of Tomudex in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Research Committee(s)
Head and Neck Cancer
Activated
06-15-1996
Closed
11-01-1997